Physician profile
Peter E Oley
NPI 1104232206
$1,628.79
in general payments reported to CMS, 2019-2025
19 companies · $611 in 2025
The $611 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.97 · 2021: $239 · 2022: $87.16 · 2023: $163 · 2024: $517 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,291.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $304.13 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $263.84 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $149.30 | 2024-2025 | |
| Novo Nordisk INC | $146.53 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Boston Scientific Corporation | $111.46 | 2023 | Wavewriter Alpha Prime 16 |
| Bayer Healthcare Pharmaceuticals INC. | $90.49 | 2023-2025 | |
| Abbvie INC. | $82.55 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.98 | 2024-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.35 | 2021-2025 | Jardiance |
| Exact Sciences Corporation | $60.77 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $52.92 | 2024-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Amgen INC. | $49.16 | 2025 | Repatha, Otezla |
| Xeris Pharmaceuticals, INC. | $45.88 | 2024-2025 | Gvoke Hypopen |
| Indivior INC. | $39.03 | 2024-2025 | Sublocade |
| Amarin Pharma, INC. | $23.11 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $20.71 | 2025 | Inspire |
| Phathom Pharmaceuticals, INC. | $19.86 | 2025 | Voquezna |
| Abbott Laboratories | $19.75 | 2025 | Freestyle Libre 3 |
| Orexo US, INC. | $11.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Oley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.